Washington SB 6506: Concerning improving diversity in clinical trials.

Status: First reading, referred to Health & Long Term Care. (as of 2018-01-22)

State: Washington · Session: 2017-2018 · Bill: SB 6506

Subjects: DRUGS, HEALTH CARE, INSTITUTIONAL REVIEW BOARD, WASHINGTON STATE, MINORITIES, WOMEN

Sponsors: Rivers, Becker, Fain

View Washington SB 6506 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.